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The identification of protective immune responses pre-
venting progression towards AIDS is critical for the design
of prophylactic and therapeutic vaccines against HIV
infection. We study 3 cohorts of chronically SIV-infected
macaques controlling viral replication for long periods of
time. These animals were monitored for plasma viremia
and the presence of SIV specific T-cell memory subsets
using intracellular staining and 10-parameters flow
cytometry. We found preservation of central memory T
cells (CM), defined as CD3+ CD45RA- CD28+ in the 3
cohorts of 'controllers'. We also found that a subset of SIV-
gag-specific CD4+ CM cells was preserved in all the
macaques with significant control of viremia, whereas this
population was absent in macaques with progressive dis-
ease. Animals with progressive disease had increased
CD8+T cell responses with effector memory (EM) pheno-
type. Our goal is to optimize DNA vaccination to induce
the subset of SIV-specific CD4+ CM.
DNA vaccination using a mixture of SIV antigens and
cytokine DNA as molecular adjuvants together with
improved DNA delivery resulted in high and broad
immune responses, including high levels of SIV specific
CD4+ CM cells. Our results demonstrate that preservation
of SIV-specific CD4+IFNgamma+ CM T cells in infected
macaques correlate with control of viremia and lack of
progression towards immunodeficiency; DNA vaccina-
tion approaches are able to recruit this subset of cells.
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